Page 3 - Biological Sample News Today

Alterity Therapeutics has received the MHRA acceptance for its request to proceed with Phase II trial of ATH434 in MSA.

Priothera has announced plans to commence Phase IIb/III trial of mocravimod in acute myeloid leukaemia patients undergoing allogeneic HSCT.

Shionogi has reported data from two trials of Covid-19 antiviral, S-217622, that concluded in Asia demonstrated rapid clearance of the virus.

Clinical Trials Arena looks at a potential shake-up in alopecia areata's treatment paradigm and an emerging treatment mechanism.

Sorrento Therapeutics has obtained the US FDA clearance to initiate the Phase II/III trial of Abivertinib in hospitalised Covid-19 patients.

/PRNewswire/ -- The "Biopreservation Media Providers Market by Preservation Condition/Deep Frozen, and Cryogenic/LN2 Vapor Phase Storage), Type of Serum, Type...

INTRODUCTION Over the past few years, there has been an evident growth in the pipeline of cell-based products, fueled by the demand for effective...

Ukraine’s conflict has knock-on effects on the Covid-19 pandemic as supplies of Sputnik V vaccine to Asian, African, and South American countries now in question.

Arrowhead Pharmaceuticals has dosed the first participants in Phase I/II trial of ARO-C3 to treat complement-mediated diseases.

Resverlogix has expanded the Phase IIb clinical trial for analysing apabetalone (RVX-208) as a potential oral Covid-19 therapy to Brazil.